arrow
S

Siegfried Schmidt

State University System of Florida
H指数:19
被引数:1,476

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Protocol for a Single-Arm Pilot Clinical Trial: Developing and Evaluating a Machine Learning Opioid Prediction & Risk-Stratification E-Platform (DEMONSTRATE)

单臂试点临床试验方案:开发与评估机器学习阿片类药物预测与风险分层电子平台(DEMONSTRATE)

2025-12-010
OAAI
Applying evidence-based cross-disciplinary concepts helps to explain the heterogeneity in pain, function, and biological measures in individuals with knee pain with/at risk of osteoarthritis
2025-02-010
OAAI
Clinical and Adverse Outcomes Associated With Concomitant Use of CYP2D6-Metabolized Opioids With Antidepressants in Older Nursing Home Residents A Target Trial Emulation Study

老年疗养院居民同时使用CYP2D6-Metabolized阿片类药物和抗抑郁药相关的临床和不良结局目标试验模拟研究

2024-08-011
PRE
Pain intensity, physical function, and depressive symptoms associated with discontinuing long-term opioid therapy in older adults with Alzheimer's disease and related dementias

在患有阿尔茨海默病和相关痴呆症的老年人中,与停止长期阿片类药物治疗相关的疼痛强度,身体功能和抑郁症状

2023-10-192
OA
A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence
2022-05-210
OAAI
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
2021-01-13201
OAAI
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity Scores
2020-11-0317
OAAI
Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings

跨门诊护理环境实施多个基因-药物对的临床药物遗传学的挑战和经验教训

2019-10-0152
OAAI
CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial
2019-08-01103
OAAI